此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

鞋类产生的生物力学操作对压力性尿失禁症状的影响 (SUI)

2026年8月19日 更新者:Montefiore Medical Center
FGBMM(鞋类产生的生物力学操作)影响骨盆肌肉的神经肌肉模式。 虽然据我们所知还没有已发表的研究调查 FGBMM 对尿失禁的影响,但 FGBMM 会引起平衡和步态的扰动,从而产生类似于动态腰骶稳定练习的动力学。 研究人员提出,FGBMM 会引起与 LPSE(腰骨盆稳定练习)相同的生物力学改善,后者已显示出对尿失禁有益。 FGBMM 中使用的鞋子可以经过校准,使患者在没有意识到的情况下发生这种共同收缩,而不是像 LPSE 通常那样指导患者共同收缩下躯干和骨盆底肌肉。 有益的骨盆和脊柱定位也可以通过策略性地放置吊舱来实现,而无需指导患者进行复杂的操作。 利用 FGBMM 在相关条件下的出色依从性和临床益处,研究人员建议评估 FGBMM 与盆底疗法一起改善城市内城区人口压力性尿失禁症状的效果。

研究概览

地位

完全的

条件

干预/治疗

详细说明

FGBMM(鞋类产生的生物力学操作)影响骨盆肌肉的神经肌肉模式。 虽然据我们所知还没有已发表的研究调查 FGBMM 对尿失禁的影响,但 FGBMM 已被证明会引起平衡和步态的扰动,从而产生类似于动态腰骶稳定练习的动力学。 为支持这一理论,该技术的创始人之一 Avi Elbaz 指出了轶事证据,表明患有 SUI(压力性尿失禁)并因膝痛或腰痛接受 FGBMM 的患者报告尿失禁有所改善,尽管该理论尚未发表,但仍支持该理论。 研究人员提出,FGBMM 会引起与 LPSE(腰骨盆稳定练习)相同的生物力学改善,后者已显示出对尿失禁有益。 鞋上的吊舱可以定位,以类似于 LPSE 中使用蹦床的方式挑战患者的平衡。 FGBMM 中使用的鞋子可以经过校准,使患者在没有意识到的情况下发生这种共同收缩,而不是像 LPSE 通常那样指导患者共同收缩下躯干和骨盆底肌肉。 有益的骨盆和脊柱定位也可以通过策略性地放置吊舱来实现,而无需指导患者进行复杂的操作。 FGBMM 的另一个优点是,该练习是在增加腹内压的情况下完成的,模拟失禁发生时的情况和环境,而不是 PFT 中使用的静态练习。 在进行常规活动的同时,人们会自然地蹲下并进行其他增加腹内压的活动。 此外,FGBMM 对于日程繁忙的人来说更实用,因为与传统的 PFT 相比,它可以在患者投入更少的时间的情况下完成,因为它是在正常活动期间完成的。 利用 FGBMM 在相关条件下的出色依从性和临床益处,研究人员建议评估 FGBMM 与盆底疗法一起改善城市内城区人口压力性尿失禁症状的效果。

FGBMM 的潜在用途是使用鞋子作为传统骨盆底疗法的补充,可能会产生更有效的治疗和更好的依从性。 传统疗法的问题包括患者依从性差(患者通常未完成疗程且依从性差(约 50%))、正在进行的计划缺乏延续性,导致复发并需要重新治疗,甚至临床获益甚微。 此外,由于没有足够的可用门诊治疗服务来满足所有患者的需求,许多患者获得盆底治疗的机会有限。 从患者护理和成本管理的角度来看,寻找一个额外的锻炼计划可以提高依从性并改善患者结果并获得更好的临床益处是当务之急。

FGBMM 使用鞋子可能会克服许多这些问题,改善/修改骨盆底肌肉的异常生物力学(因此减少尿失禁),以及利用鞋子通过促进扰动引起正常活动锻炼的家庭锻炼计划。 这种生物力学方法可以显着改善压力性 SUI 或混合性尿失禁患者的尿失禁症状。 利用已报告的 FGBMM 在相关病症患者中的出色依从性和临床益处,研究人员建议评估生物力学锻炼(每天在家穿经过适当校准的鞋子达到规定的时间)作为一种保守治疗,可能补充传统的骨盆底疗法、药物治疗,甚至是内城区人口的手术干预。

研究类型

介入性

注册 (实际的)

64

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

研究联系人备份

学习地点

    • New York
      • The Bronx、New York、美国、10461
        • Montefiore Medical Center - Medical Park Campuses

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 至 75年 (成人、年长者)

接受健康志愿者

不

描述

纳入标准:

  • 压力性或混合性尿失禁,基于 UDI-6。
  • 18-75岁之间的女性。
  • 重量小于 350 磅。
  • 可以参加包括每日步行在内的康复计划的门诊和活跃患者
  • 能够步行至少 50 米,并且在 STEADI 测试中得分为阳性
  • 能够理解、阅读并签署知情同意书
  • 说英语或西班牙语

排除标准:

  • 失禁手术前
  • 过去 6 个月内接受盆底治疗。
  • 目前怀孕
  • 主要是急迫性尿失禁。
  • 患者在过去 52 周内跌倒超过 3 次,或在过去 52 周内因受伤导致任何与平衡相关的跌倒。
  • 表现出缺乏执行或遵守研究程序的身体或精神能力的患者。
  • 有病理性骨质疏松性骨折病史的患者
  • 禁止参加积极锻炼计划的任何主要心血管合并症
  • 活动性心脏病(24 周内缺血或心力衰竭入院)和活动性 COPD(24 周内恶化)
  • 正在进行治疗的活动性恶性肿瘤
  • 具有神经步态模式的患者。
  • 在步态分析期间需要辅助设备的患者。

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:无(打开标签)

武器和干预

参与者组/臂
干预/治疗
有源比较器:Traditional Pelvic Floor Physical Therapy (PFPT)
Up to six sessions, with one session every alternate week.
Participant will receive six sessions of PFPT, up-to one sessions every alternate week. This will involve exercise and modalities as decided by medical providers and therapists. Participants will also have a home exercise program prescribed along with each session and for the remainder of six months.
实验性的:FGBMM plus Traditional Pelvic Floor Physical Therapy (PFPT)
Treatment with FGBMM using shoes with pertupods daily at home along with traditional pelvic floor therapy sessions.
Participants will have FGBMM using shoes with pertupods along with traditional PFPT over the course of six months. This will include five sessions of gait assessment and re-calibration with daily at home exercise with the device (shoes) over the course of six months. Along with that, participant will receive traditional pelvic floor therapy of six sessions, up-to one sessions every alternate week. This will involve exercise and modalities as decided by medical providers and therapists. Participants will also have a home exercise program prescribed along with each session and for the remainder of six months.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Severity of Stress Urinary Incontinence (SUI) Symptoms
大体时间:Baseline, 4 weeks, 8 weeks, 12 weeks, and 24 weeks (~Six months)
Severity of SUI symptoms was measured using the six-item Urogenital Distress Inventory (UDI-6). The UDI-6 is a validated, patient-reported questionnaire which assesses the severity of symptoms of urinary incontinence. It includes questions evaluating the frequency of urination, incontinence/leakage, difficulty with complete bladder emptying, and pain. Responses on the UDI-6 are rated on a 5-point scale ranging from 0 ("No/Not present") to 4 ("Quite a bit"). Raw scores were summed, averaged, and multiplied by 25 to yield a final score scale ranging from 0-100. Higher scores are indicative of greater distress due to symptom severity. Results are summarized by study arm.
Baseline, 4 weeks, 8 weeks, 12 weeks, and 24 weeks (~Six months)

次要结果测量

结果测量
措施说明
大体时间
Quality of Life as Determined by the Urinary Impact Questionnaire (UIQ-7)
大体时间:Baseline, 4 weeks, 8 weeks, 12 weeks, and 24 weeks (~Six months)
Quality of Life will be determined with the use of the UIQ-7 subscale component of the Pelvic Floor Impact Questionnaire-short form 7 (PFIQ-7) questionnaire. Specifically, the UIQ-7 questions within the PFIQ-7 are used to assess the impact of bladder or urine symptoms or conditions on a participant's daily function and activities, social health, or mental health over the prior 3 months. Participants provide responses for each question on 4-point scale ranging from 0 ("Not at all") to 3 ("Quite a bit"). Mean scores are averaged and multiplied by 100/3 to yield an overall possible score of 0-100, such that higher scores are indicative of a greater negative impact on quality of life from pelvic floor dysfunction. Scores are summarized by study arm using basic descriptive statistics.
Baseline, 4 weeks, 8 weeks, 12 weeks, and 24 weeks (~Six months)
Pelvic Floor Muscle (PFM) Activity - Average Contraction
大体时间:Baseline, 4 weeks, 8 weeks, 12 weeks, and 24 weeks (~Six months)
PFM Activity was assessed during each visit by surface electromyography (sEMG). sEMG recording of the pelvic floor muscle activity was conducted via the use of Prometheus CTS 2000 EMG machine and vaginal sensor for optimal recording and was performed after pelvic examinations had been done to ensure there were no contraindications for the use of the probe. Neuromuscular electrical stimulation with 50 HZ was done via the use of the same intra-vaginal probe for the enhancement of the pelvic floor muscles. Electrical signals (microvolts) were measured during specific tasks and PFM average contraction, maximum contraction, and average rest results were calculated and reported in microvolts. Increased amplitude in waveforms, and corresponding result values, were associated with stronger muscle activation and decreased urinary incontinence. Average contraction results values are summarized by study arm using basic descriptive statistics.
Baseline, 4 weeks, 8 weeks, 12 weeks, and 24 weeks (~Six months)
Pelvic Floor Muscle (PFM) Activity - Maximum Contraction
大体时间:Baseline, 4 weeks, 8 weeks, 12 weeks, and 24 weeks (~Six months)
PFM Activity was assessed during each visit by surface electromyography (sEMG). sEMG recording of the pelvic floor muscle activity was conducted via the use of Prometheus CTS 2000 EMG machine and vaginal sensor for optimal recording and was performed after pelvic examinations had been done to ensure there were no contraindications for the use of the probe. Neuromuscular electrical stimulation with 50 HZ was done via the use of the same intra-vaginal probe for the enhancement of the pelvic floor muscles. Electrical signals (microvolts) were measured during specific tasks and PFV average contraction, maximum contraction, and average rest results were calculated and reported in microvolts. Increased amplitude in waveforms, and corresponding result values, were associated with stronger muscle activation and decreased urinary incontinence. Maximum contraction results values are summarized by study arm using basic descriptive statistics.
Baseline, 4 weeks, 8 weeks, 12 weeks, and 24 weeks (~Six months)
Pelvic Floor Muscle (PFM) Activity - Average Rest
大体时间:Baseline, 4 weeks, 8 weeks, 12 weeks, and 24 weeks (~Six months)
PFM Activity was assessed during each visit by surface electromyography (sEMG). sEMG recording of the pelvic floor muscle activity was conducted via the use of Prometheus CTS 2000 EMG machine and vaginal sensor for optimal recording and was performed after pelvic examinations had been done to ensure there were no contraindications for the use of the probe. Neuromuscular electrical stimulation with 50 HZ was done via the use of the same intra-vaginal probe for the enhancement of the pelvic floor muscles. Electrical signals (microvolts) were measured during specific tasks and PFV average contraction, maximum contraction, and average rest results were calculated and reported in microvolts. Increased amplitude in waveforms, and corresponding result values, were associated with stronger muscle activation and decreased urinary incontinence. Average rest results values are summarized by study arm using basic descriptive statistics.
Baseline, 4 weeks, 8 weeks, 12 weeks, and 24 weeks (~Six months)
Pelvic Floor Muscle (PFM) Activity - Change From Average Contraction to Average Rest
大体时间:Baseline, 4 weeks, 8 weeks, 12 weeks, and 24 weeks (~Six months)
PFM Activity was assessed during each visit by surface electromyography (sEMG). sEMG recording of the pelvic floor muscle activity was conducted via the use of Prometheus CTS 2000 EMG machine and vaginal sensor for optimal recording and was performed after pelvic examinations had been done to ensure there were no contraindications for the use of the probe. Neuromuscular electrical stimulation with 50 HZ was done via the use of the same intra-vaginal probe for the enhancement of the pelvic floor muscles. Electrical signals (microvolts) were measured during specific tasks and PFV average contraction, maximum contraction, and average rest results were calculated and reported in microvolts. Increased amplitude in waveforms, and corresponding result values, were associated with stronger muscle activation and decreased urinary incontinence. Change From Average Contraction to Average Rest results values are summarized by study arm using basic descriptive statistics.
Baseline, 4 weeks, 8 weeks, 12 weeks, and 24 weeks (~Six months)
Pelvic Floor Muscle (PFM) Activity - Average Abdominal Contraction
大体时间:Baseline, 4 weeks, 8 weeks, 12 weeks, and 24 weeks (~Six months)
PFM Activity was assessed during each visit by surface electromyography (sEMG). sEMG recording of the pelvic floor muscle activity was conducted via the use of Prometheus CTS 2000 EMG machine and vaginal sensor for optimal recording and was performed after pelvic examinations had been done to ensure there were no contraindications for the use of the probe. Neuromuscular electrical stimulation with 50 HZ was done via the use of the same intra-vaginal probe for the enhancement of the pelvic floor muscles. Electrical signals (microvolts) were measured during specific tasks and PFV average contraction, maximum contraction, and average rest results were calculated and reported in microvolts. Increased amplitude in waveforms, and corresponding result values, were associated with stronger muscle activation and decreased urinary incontinence. Average Abdominal Contraction results values are summarized by study arm using basic descriptive statistics.
Baseline, 4 weeks, 8 weeks, 12 weeks, and 24 weeks (~Six months)
Adherence to Treatment
大体时间:Baseline to 24 weeks (~Six months)
Adherence to FGBMM and PFPT was assessed based on self-reporting of in-person PFPT visits and in-person calibration visits (Dual Therapy study arm only) on an end of study questionnaire. Median number of visits is calculated and summarized by study arm.
Baseline to 24 weeks (~Six months)

其他结果措施

结果测量
措施说明
大体时间
Total Healthcare Costs
大体时间:Baseline, 4 weeks, 8 weeks, 12 weeks, and 24 weeks (~Six months)
Total costs associated with PFPT or PFPT+FGBMM will be summarized. Costs will include those associated with physical therapy, emergency department (ED) visits, medications, imaging studies, surgical procedures, physician visits related to symptoms of incontinence, and total physician visits. Mean costs will be summarized by study arm.
Baseline, 4 weeks, 8 weeks, 12 weeks, and 24 weeks (~Six months)
Gait Assessment
大体时间:Six months
The gait assessment consists of the Spatio-temporal gait assessment including the following parameters: gait velocity, cadence, step length, gait cycle phases, step width, toe-in/out angle, center of pressure trajectory single limb support and limb symmetry measured by gait analysis. Results will be summarized by study arm.
Six months
Change in Total Healthcare Utilization
大体时间:6 months
Change in total healthcare facility utilization, including physical therapy, ED visits, pharmacological treatments, imaging studies, surgical procedures, physician visits related to symptoms of incontinence and total physician visits, as assessed by patient interview.
6 months

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

赞助

合作者

调查人员

  • 首席研究员:Anna M Lasak, MD、Montefiore Medical Center

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

一般刊物

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2017年11月29日

初级完成 (实际的)

2023年12月12日

研究完成 (实际的)

2023年12月12日

研究注册日期

首次提交

2017年6月19日

首先提交符合 QC 标准的

2017年6月20日

首次发布 (实际的)

2017年6月21日

研究记录更新

最后更新发布 (实际的)

2026年9月14日

上次提交的符合 QC 标准的更新

2026年8月19日

最后验证

2026年8月1日

更多信息

与本研究相关的术语

其他研究编号

  • 2016-7163

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

IPD 计划说明

未决定共享数据。

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

是的

在美国制造并从美国出口的产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.